Advertisement

Interactions of Neuropeptides with Cholinergic Septal-Hippocampal Pathway: Indication for a Possible Trans-Synaptic Regulation

  • P. L. Wood
  • D. L. Cheney
  • E. Costa
Part of the Advances in Behavioral Biology book series (ABBI, volume 25)

Abstract

The peculiar way in which the brain processes, stores and retrieves information is determined by an interplay of biochemical and electrical mechanisms which are contained and function within complex neuronal loops. The nature of these interactions and the way in which they relate to information processing is not understood. These circuits possess intrinsic regulatory features presumably related to memory which are dependent upon feedback and extrinsic modulatory influences for their function. Modulatory processes by definition include local interneurons, afferent fibers from other brain nuclei and neuroendocrine factors. The coexistence of neuropeptides with other primary transmitters in neurons adds further flexibility to the system but reduces our ability to comprehend the neurochemical processes in defined anatomical pathways. Thus, more sensitive and specific techniques are required to study these processes. To this end we have used gas chromatography mass spectrometry (GCMS) to examine the actions of peptides on the activity of the septal hippocampal cholinergic pathway (SHCP). The assay of acetylcholine turnover (TRAch) by GCMS has been shown to be an accurate index for estimating biochemically the activity of septal cholinergic neurons (13).

Keywords

GABAergic Interneuron Primary Transmitter Local Interneuron Dopaminergic Innervation Electrical Mechanism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Annunziato, L. and Moore, K.E. (1978): Life Sci. 22:2037–2042.CrossRefGoogle Scholar
  2. 2.
    Biscoe, T.J. and Straughan, D.W. (1966): J. Physiol, 183:341–359.Google Scholar
  3. 3.
    Cheney, D.L., Robinson, S.E., Malthe-Sorenssenf, D. Wood, P.L. Commissiong, J.W. and Costa, E. (1979): Adv. Pharmacol. Ther. 5: 241–250.Google Scholar
  4. 4.
    Clemens, J.A. and Sawyer, B.D. (1974): Exp. Brain Res. 21:399–402.CrossRefGoogle Scholar
  5. 5.
    Cuello, A.C. and Kanazawa, I. 1978): J. Comp. Neurol. 178:129–156.CrossRefGoogle Scholar
  6. 6.
    Fixe, K., Hokfelt, T., Eneroth, P., Gustafsson, J.-A. and Skett, P. (1977): Science 196:899–900.CrossRefGoogle Scholar
  7. 7.
    Hokfelt, T. and Fuxe, K. (1972): Neuroendocrinology 9:100–122.CrossRefGoogle Scholar
  8. 8.
    Lewis, P.R. and Shute, C.C.D. (1967): Brain 90:521–540.CrossRefGoogle Scholar
  9. 9.
    Login, I.S. and MacLeod, R.M. (1977): Brain Res. 132:477–483.CrossRefGoogle Scholar
  10. 10.
    Malthe-Sorenssen, D., Cheney, D.L. and Costa, E. (1978):J. Pharmacol. Exp. Ther. 206:21–28.Google Scholar
  11. 11.
    Malthe-Sorenssen, D., Wood, P.L., Cheney, D.L. and Costa, E. (1978): J. Neurochem. 31:685–691.CrossRefGoogle Scholar
  12. 12.
    Moroni, F., Cheney, D.L. and Costa, E. (1977); Naun.-Schmied. Arch. Pharmacol. 299:149–153.CrossRefGoogle Scholar
  13. 13.
    Moroni, F., Malthe-Sorenssen, D., Cheney, D.L. and Costa, E, (1978): Brain Res. 150:333–341.CrossRefGoogle Scholar
  14. 14.
    Paxinos, G., Emson, P.C. and Cuello, A.C. (1978): Neurosci, Lett. 7:133–136.CrossRefGoogle Scholar
  15. 15.
    Perkins, N.A. and Westfall, T.C. (1978): Neuroscience. 3:59–63.CrossRefGoogle Scholar
  16. 16.
    Petrusz, P., Sar, M., Grossman, G.H. and Kizer, J.S. (1977):Brain Res. 137:181–187.CrossRefGoogle Scholar
  17. 17.
    Robinson, S.E., Malthe-Sorenssen, D., Wood, P.L. and Commissiong, J. (1979): J. Pharmacol. Exp. Ther., 208:476–479.Google Scholar
  18. 18.
    Storm-Mathisen, J. and Opsahl, M.W. (1978): Neurosci, Lett. 9: 65–70.CrossRefGoogle Scholar
  19. 19.
    Tappaz, M.L., Brownstein, M.J. and Palkovits, M. (1976): Brain Res. 108:371–379.CrossRefGoogle Scholar
  20. 20.
    Watson, S.J. and Barchas, J.D. (1979): In Mechanisms, of Pain and Analgesic Compounds (eds) R.F. Beers Jr. and E.G. Bassett, Pergamon Press, New York, pp. 227–237.Google Scholar
  21. 21.
    Wood, P.L., Malthe-Sorenssen, D., Cheneyi D.L. and Costa, E. (1978): Life Sci. 22:673–678.CrossRefGoogle Scholar
  22. 22.
    Wood, P.L., Cheney, D.L. and Costa, E. (1978): J. Pharmacol. Exp. Ther. 209:97–103.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • P. L. Wood
    • 2
  • D. L. Cheney
    • 1
  • E. Costa
    • 1
  1. 1.Laboratory of Preclinical Pharmacology, National Institute of Mental HealthSt. Elizabeths HospitalUSA
  2. 2.Department of PharmacologyMerck Frosst LaboratoryDorval 700Canada

Personalised recommendations